@article{article, title  = {{Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party}},

 publisher = {{American Society of Hematology}},

 url = {{http://dx.doi.org/10.1182/blood-2022-162277 }},

 year = {{2022}},

 month = {{11}},

 author = {{Duque Afonso J and Finke J and Ngoya M and Galimard J-E and Craddock C and Raj K and Bloor A and Nicholson E and Eder M and Orchard KH and Valerius T et al}},

 doi = {{10.1182/blood-2022-162277}},

 volume = {{140}},

 journal = {{Blood}},

 issue = {{Supplement 1}},

 pages = {{2110-2112}},

 note = {{Accessed on 2024/12/22}}}